Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
about
Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes.Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study
P2860
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@ast
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@en
type
label
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@ast
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@en
prefLabel
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@ast
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@en
P2093
P2860
P1433
P1476
Clinical benefit of adding oxa ...... t treatment for rectal cancer.
@en
P2093
Anna Lisa Magnante
Daniela Musio
Francesca De Felice
Ilaria Benevento
Nadia Bulzonetti
Rossella Caiazzo
Vincenzo Tombolini
P2860
P2888
P356
10.1186/S12885-017-3323-4
P407
P577
2017-05-12T00:00:00Z
P6179
1085378692